Eledon Pharmaceuticals In... (ELDN)

AI Score

Unlock

3.27

0.03 (0.93%)

At close: Apr 28, 2025, 9:30 AM

Eledon Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-44.62M	63.63M	-44.91M	-10.29M	-9.63M	-10.35M	-9.58M	-10.77M	-58.38M	-10.47M	-9.25M	-9.86M	-8.81M	-9.82M	-7.38M	-8.5M	-5.9M	-6.14M	-2.59M	-8.18M	-4.14M	-2.89M	-4.09M	-4.88M	-4.57M	-3.5M	-3.19M	-2.81M	-2.11M	-2.97M	-4.17M	-3.87M	-3.74M	-9.27M	-13.53M	-11.43M
Depreciation & Amortization	88K	79K	97K	95K	94K	94K	94K	92K	93K	93K	94K	93K	61K	44K	44K	46K	45K	46K	46K	46K	46K	46K	45K	45K	3K	3K	2K	3K	4K	2K	-1K	17K	17K	49K	52K	53K
Stock-Based Compensation	6.58M	1.78M	3.06M	1.69M	1.71M	1.73M	1.72M	1.38M	1.47M	2.19M	2.31M	2.19M	2.05M	2.04M	2.03M	1.77M	1.66M	878K	197K	437K	243K	227K	627K	211K	740K	238K	404K	161K	193K	150K	130K	106K	342K	57K	-937K	1.02M
Other Working Capital	-477K	-9.97M	1.37M	-186K	-1.69M	-1.24M	226K	1.02M	-3.39M	709K	1.67M	830K	-4.08M	1.32M	-1.55M	-206K	-4.79M	4.66M	-678K	116K	1.36M	-269K	-1.5M	65K	-465K	169K	-551K	192K	1.09M	-599K	-1.49M	482K	-3.48M	94K	2.19M	-104K
Other Non-Cash Items	20.05M	-73.84M	30.81M	933K	265K	-1.73M	-1.72M	2.58M	48.65M	-542K	2.14M	3.77M	2.01M	760K	3.73M	-354K	-4.45K	-6.14M	-785	4.83M	1.87M	-291	-1.3K	537.00	618K	152.00	-167	179.00	18K	150K	-135K	373K	8K	268K	1.03M	1.06M
Deferred Income Tax	431K	n/a	n/a	n/a	-889K	1.25M	1.62M	-2.58M	n/a	542K	-2.14M	n/a	-579K	-686K	-588K	-501K	-404K	6.14M	n/a	n/a	n/a	n/a	n/a	n/a	-618K	n/a	n/a	n/a	n/a	-150K	164K	-371K	n/a	n/a	-994K	-1.02M
Change in Working Capital	-1.52M	-3.42M	3.16M	265K	-685K	-3.25M	-359K	-625K	-1.31M	3.62M	628K	-571K	-1.94M	1.32M	-1.55M	2.01M	-4.83M	4.66M	-678K	668K	-35K	-269K	-1.5M	602K	478K	320K	-551K	371K	-716K	-599K	-1.49M	328K	-3.94M	-866K	2.15M	574K
Operating Cash Flow	-18.99M	-11.77M	-7.77M	-8.74M	-9.13M	-12.25M	-8.22M	-9.92M	-9.48M	-4.57M	-6.22M	-8.16M	-9.21M	-7.09M	-7.45M	-5.17M	-9.43M	-561K	-3.02M	-2.2M	-2.02M	-2.89M	-4.92M	-4.02M	-3.35M	-2.94M	-3.33M	-2.27M	-2.61M	-3.42M	-5.76M	-3.15M	-7.31M	-9.17M	-10.3M	-9.74M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.00	-2K	-5	-17K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23.25K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-72.78M	-34.12M	-36.31M	-12.92M	-17.92M	-30.03M	-30.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-502K	n/a	n/a	n/a
Sales Maturities Of Investments	25.4M	21.32M	16.4M	22.7M	28M	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.17M	n/a	n/a	4.17M	11.9M	15.65M	n/a	n/a
Other Investing Acitivies	1.00	-1	n/a	9.78M	10.08K	-25.03K	-30.33K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	18.93M	150K	502K	n/a	8.15M	n/a
Investing Cash Flow	-47.38M	-12.8M	-19.91M	9.78M	10.08M	-25.03M	-30.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.04M	11.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.17M	n/a	18.93M	4.33M	11.9M	15.65M	8.15M	-17K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	215K	n/a	n/a	n/a	-33.02K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-451K	1K	n/a	-450K	164K	95.23M	n/a	5.19M	n/a	n/a	n/a	n/a	n/a	70K	n/a	n/a	n/a	n/a	n/a	400K	-37K	2.93M	-37K	37K
Financial Cash Flow	80.17M	5.28M	48.07M	1K	n/a	n/a	33.02M	n/a	n/a	n/a	n/a	n/a	-450K	1K	n/a	-450K	9.16M	95.23M	n/a	5.19M	n/a	n/a	9.57M	107K	1K	70K	n/a	7.49M	750K	n/a	7.12M	400K	n/a	2.93M	-37K	37K
Net Cash Flow	13.8M	-19.29M	20.38M	1.04M	945K	-37.28M	-5.54M	-9.92M	-9.48M	-4.57M	-6.22M	-8.16M	-9.21M	-7.09M	-7.45M	-5.62M	-269K	105.7M	-3.02M	2.99M	-2.02M	-2.89M	4.65M	-3.92M	-3.35M	-2.87M	-3.33M	5.22M	-1.86M	-3.42M	-1.82M	1.18M	4.59M	6.47M	-2.15M	-9.72M
Free Cash Flow	-18.99M	-11.77M	-7.77M	-8.74M	-9.13M	-12.25M	-8.22M	-9.92M	-9.48M	-4.57M	-6.22M	-8.16M	-9.21M	-7.09M	-7.45M	-5.17M	-9.43M	-561K	-3.02M	-2.2M	-2.02M	-2.89M	-4.92M	-4.02M	-3.35M	-2.94M	-3.33M	-2.27M	-2.61M	-3.42M	-5.76M	-3.15M	-7.31M	-9.18M	-10.3M	-9.76M